DONACO INTERNATIONAL LIMITED - Announcements

Market Cap $49.41M Add to my watchlist

Consumer Cyclical Resorts & Casinos

Donaco International Limited is an Australia-based company, which operates leisure and... Donaco International Limited is an Australia-based company, which operates leisure and hospitality businesses across the Asia Pacific region. The Company’s segments include Casino Operations-Vietnam, Casino Operations-Cambodia, and Corporate Operations. The Casino Operations-Vietnam segment is comprised of the Aristo International Hotel operating in Vietnam. These operations include hotel accommodation, and gaming and leisure facilities. The Casino Operations-Cambodia segment comprises the Star Vegas Resort and Club, operating in Cambodia. Its operations include hotel accommodation and gaming and leisure facilities. The Corporate Operations segment consists of development and implementation of corporate strategy, commercial negotiations, corporate finance, treasury, management accounting, corporate governance, and investor relations functions. Its Star Vegas Resort and Club is a casino resort in Poipet. The Aristo International Hotel is located on the border between China and Vietnam.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

DNA	Quarterly Activities and Cashflow Reports	PRICE SENSITIVE	24/04/24	456.41KB	Share
DNA	1H FY24 Investor Presentation	PRICE SENSITIVE	28/02/24	1.55MB	Share
DNA	1H FY24 Results Summary	PRICE SENSITIVE	28/02/24	235.29KB	Share
DNA	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	28/02/24	700.6KB	Share
DNA	Quarterly Activities and Cashflow Reports	PRICE SENSITIVE	30/01/24	533.09KB	Share
DNA	2023 AGM Results		24/11/23	216.41KB	Share
DNA	2023 AGM Presentation		24/11/23	1.37MB	Share
DNA	2023 AGM Chair's Address		24/11/23	180.25KB	Share
DNA	Quarterly Activities and Cashflow Reports	PRICE SENSITIVE	30/10/23	528.4KB	Share
DNA	Notice of Annual General Meeting/Proxy Form		25/10/23	820.5KB	Share
DNA	Change of Auditor		19/10/23	161.41KB	Share
DNA	Annual General Meeeting Information		29/09/23	156.19KB	Share
DNA	FY23 Corporate Governance Statement and Appendix 4G		29/09/23	475.2KB	Share
DNA	FY23 Annual Report and Audited Accounts		29/09/23	999.66KB	Share
DNA	Appointment of Company Secretary		19/09/23	148.67KB	Share
DNA	FY23 Results Presentation	PRICE SENSITIVE	31/08/23	859.25KB	Share
DNA	FY23 Results Commentary	PRICE SENSITIVE	31/08/23	209.71KB	Share
DNA	Preliminary Final Report	PRICE SENSITIVE	31/08/23	1.33MB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	31/07/23	262.7KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/23	277.11KB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	28/04/23	247.89KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/23	218.42KB	Share
DNA	1H FY23 Results Summary	PRICE SENSITIVE	01/03/23	190.9KB	Share
DNA	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	28/02/23	1.06MB	Share
DNA	Details of Share Registry		06/02/23	147.57KB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	31/01/23	334.69KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/23	219.24KB	Share
DNA	Constitution		25/11/22	507.59KB	Share
DNA	Results of Meeting		25/11/22	150.55KB	Share
DNA	Chairman's Address to Shareholders		25/11/22	182.87KB	Share
DNA	FY22 AGM Presentation		22/11/22	984.8KB	Share
DNA	Appendix 4C Cash Flow Report (Amended)	PRICE SENSITIVE	31/10/22	427.26KB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	28/10/22	243.05KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/22	220.87KB	Share
DNA	Notice of Annual General Meeting/Proxy Form		24/10/22	810.79KB	Share
DNA	Response to Price Query	PRICE SENSITIVE	05/10/22	374.66KB	Share
DNA	FY22 Annual Report and Audited Accounts		28/09/22	917.99KB	Share
DNA	Appendix 4G and FY22 Corporate Governance Statement		30/08/22	452.48KB	Share
DNA	FY22 Results Presentation	PRICE SENSITIVE	30/08/22	1.32MB	Share
DNA	FY22 Results Commentary	PRICE SENSITIVE	30/08/22	296.76KB	Share
DNA	Preliminary Final Report	PRICE SENSITIVE	30/08/22	291.75KB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	29/07/22	241.63KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/22	224.32KB	Share
DNA	Star Vegas Casino Operations to Resume	PRICE SENSITIVE	17/06/22	159.45KB	Share
DNA	Loan Facility for Continued Balance Sheet Protection	PRICE SENSITIVE	02/05/22	194.96KB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	29/04/22	234.47KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/22	238.26KB	Share
DNA	1H FY22 Investor Presentation	PRICE SENSITIVE	28/02/22	1018.22KB	Share
DNA	1H FY22 Results Summary	PRICE SENSITIVE	28/02/22	187.3KB	Share
DNA	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	28/02/22	629.32KB	Share
DNA	Quarterly Activities Report & Appendix 4C - 31 December 2021	PRICE SENSITIVE	31/01/22	421.23KB	Share
DNA	Results of Annual General Meeting		28/01/22	190.39KB	Share
DNA	AGM 2021 - Investor Presentation		28/01/22	950.05KB	Share
DNA	AGM 2021 - Chairman's Address		28/01/22	165.3KB	Share
DNA	Mega Bank Facility Repaid		05/01/22	159.4KB	Share
DNA	Notice of Annual General Meeting/Proxy Form		24/12/21	1.25MB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/21	247.45KB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	29/10/21	244.64KB	Share
DNA	Appendix 4G and FY21 Corporate Governance Statement		30/09/21	424.89KB	Share
DNA	FY21 Annual Report and Audited Accounts		30/09/21	1.85MB	Share
DNA	FY21 Results Presentation		31/08/21	1.45MB	Share
DNA	FY21 Results Commentary	PRICE SENSITIVE	31/08/21	213.28KB	Share
DNA	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	31/08/21	185.21KB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	30/07/21	239.22KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/21	152.9KB	Share
DNA	Change of Registered Office Address		07/07/21	132.53KB	Share
DNA	Status of Mega Bank Facility	PRICE SENSITIVE	01/07/21	163.56KB	Share
DNA	Quarterly Activities Report & Appendix 4C - 31 March 2021	PRICE SENSITIVE	30/04/21	505.58KB	Share
DNA	Temporary Closure of Star Vegas	PRICE SENSITIVE	28/04/21	152.66KB	Share
DNA	1H FY21 Results Investor Briefing Q&A		05/03/21	239.05KB	Share
DNA	1H FY21 Investor Presentation		26/02/21	868.85KB	Share
DNA	1H FY21 Results Summary	PRICE SENSITIVE	26/02/21	210.13KB	Share
DNA	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	26/02/21	545.53KB	Share
DNA	1H FY21 Results Investor Briefing		18/02/21	152.25KB	Share
DNA	Change of Director's Interest Notice		01/02/21	369.33KB	Share
DNA	Quarterly Activities Report & Appendix 4C - 31 December 2020	PRICE SENSITIVE	29/01/21	474.53KB	Share
DNA	Donaco completes Star Vegas settlement		11/01/21	149.22KB	Share
DNA	Lender approval received for Star Vegas settlement	PRICE SENSITIVE	22/12/20	155.78KB	Share
DNA	Final Director's Interest Notice		22/12/20	171.4KB	Share
DNA	Final Director's Interest Notice		22/12/20	170.9KB	Share
DNA	Results of Meeting		21/12/20	189.58KB	Share
DNA	AGM 2020 - CEO Presentation	PRICE SENSITIVE	21/12/20	1.03MB	Share
DNA	AGM 2020 - Chairman's Address		21/12/20	165.94KB	Share
DNA	2020 AGM - Withdrawal of Resolutions 7 and 8		21/12/20	156.85KB	Share
DNA	Board Composition Changes		21/12/20	147.08KB	Share
DNA	DNA returns to positive EBITDA as COVID-19 impacts subside	PRICE SENSITIVE	18/12/20	171.48KB	Share
DNA	Virtual Meeting Online User Guide		19/11/20	891.99KB	Share
DNA	Notice of Annual General Meeting and Proxy Form		19/11/20	1.08MB	Share
DNA	Appendix 4G and FY20 Corporate Governance Statement		30/10/20	486.27KB	Share
DNA	FY20 Annual Report and Audited Accounts		30/10/20	2.01MB	Share
DNA	Quarterly Activities Report & Appendix 4C - 30 Sept 2020	PRICE SENSITIVE	30/10/20	1022.05KB	Share
DNA	Limited Reopening of DNA Star Vegas		25/09/20	149.68KB	Share
DNA	Final Director's Interest Notice - Vertullo		07/09/20	168.51KB	Share
DNA	Initial Director's Interest Notice - Intrapaiboon		03/09/20	167.41KB	Share
DNA	Final Director's Interest Notice - Ashton		03/09/20	169.56KB	Share
DNA	Initial Director's Interest Notice - Phillips		03/09/20	170.83KB	Share
DNA	Board and CEO Appointments		03/09/20	206.75KB	Share
DNA	FY20 Results Presentation		01/09/20	1.01MB	Share
DNA	FY20 Results Commentary		01/09/20	272.99KB	Share
DNA	Preliminary Final Report	PRICE SENSITIVE	01/09/20	361.69KB	Share

DNA Quarterly Activities and Cashflow Reports
24/04/24	PRICE SENSITIVE	456.41KB	Share
DNA 1H FY24 Investor Presentation
28/02/24	PRICE SENSITIVE	1.55MB	Share
DNA 1H FY24 Results Summary
28/02/24	PRICE SENSITIVE	235.29KB	Share
DNA Appendix 4D and Half Year Financial Report
28/02/24	PRICE SENSITIVE	700.6KB	Share
DNA Quarterly Activities and Cashflow Reports
30/01/24	PRICE SENSITIVE	533.09KB	Share
DNA 2023 AGM Results
24/11/23		216.41KB	Share
DNA 2023 AGM Presentation
24/11/23		1.37MB	Share
DNA 2023 AGM Chair's Address
24/11/23		180.25KB	Share
DNA Quarterly Activities and Cashflow Reports
30/10/23	PRICE SENSITIVE	528.4KB	Share
DNA Notice of Annual General Meeting/Proxy Form
25/10/23		820.5KB	Share
DNA Change of Auditor
19/10/23		161.41KB	Share
DNA Annual General Meeeting Information
29/09/23		156.19KB	Share
DNA FY23 Corporate Governance Statement and Appendix 4G
29/09/23		475.2KB	Share
DNA FY23 Annual Report and Audited Accounts
29/09/23		999.66KB	Share
DNA Appointment of Company Secretary
19/09/23		148.67KB	Share
DNA FY23 Results Presentation
31/08/23	PRICE SENSITIVE	859.25KB	Share
DNA FY23 Results Commentary
31/08/23	PRICE SENSITIVE	209.71KB	Share
DNA Preliminary Final Report
31/08/23	PRICE SENSITIVE	1.33MB	Share
DNA Quarterly Activities Report
31/07/23	PRICE SENSITIVE	262.7KB	Share
DNA Appendix 4C Cash Flow Report
31/07/23	PRICE SENSITIVE	277.11KB	Share
DNA Quarterly Activities Report
28/04/23	PRICE SENSITIVE	247.89KB	Share
DNA Appendix 4C Cash Flow Report
28/04/23	PRICE SENSITIVE	218.42KB	Share
DNA 1H FY23 Results Summary
01/03/23	PRICE SENSITIVE	190.9KB	Share
DNA Appendix 4D and Half Year Financial Report
28/02/23	PRICE SENSITIVE	1.06MB	Share
DNA Details of Share Registry
06/02/23		147.57KB	Share
DNA Quarterly Activities Report
31/01/23	PRICE SENSITIVE	334.69KB	Share
DNA Appendix 4C Cash Flow Report
31/01/23	PRICE SENSITIVE	219.24KB	Share
DNA Constitution
25/11/22		507.59KB	Share
DNA Results of Meeting
25/11/22		150.55KB	Share
DNA Chairman's Address to Shareholders
25/11/22		182.87KB	Share
DNA FY22 AGM Presentation
22/11/22		984.8KB	Share
DNA Appendix 4C Cash Flow Report (Amended)
31/10/22	PRICE SENSITIVE	427.26KB	Share
DNA Quarterly Activities Report
28/10/22	PRICE SENSITIVE	243.05KB	Share
DNA Appendix 4C Cash Flow Report
28/10/22	PRICE SENSITIVE	220.87KB	Share
DNA Notice of Annual General Meeting/Proxy Form
24/10/22		810.79KB	Share
DNA Response to Price Query
05/10/22	PRICE SENSITIVE	374.66KB	Share
DNA FY22 Annual Report and Audited Accounts
28/09/22		917.99KB	Share
DNA Appendix 4G and FY22 Corporate Governance Statement
30/08/22		452.48KB	Share
DNA FY22 Results Presentation
30/08/22	PRICE SENSITIVE	1.32MB	Share
DNA FY22 Results Commentary
30/08/22	PRICE SENSITIVE	296.76KB	Share
DNA Preliminary Final Report
30/08/22	PRICE SENSITIVE	291.75KB	Share
DNA Quarterly Activities Report
29/07/22	PRICE SENSITIVE	241.63KB	Share
DNA Appendix 4C Cash Flow Report
29/07/22	PRICE SENSITIVE	224.32KB	Share
DNA Star Vegas Casino Operations to Resume
17/06/22	PRICE SENSITIVE	159.45KB	Share
DNA Loan Facility for Continued Balance Sheet Protection
02/05/22	PRICE SENSITIVE	194.96KB	Share
DNA Quarterly Activities Report
29/04/22	PRICE SENSITIVE	234.47KB	Share
DNA Appendix 4C Cash Flow Report
29/04/22	PRICE SENSITIVE	238.26KB	Share
DNA 1H FY22 Investor Presentation
28/02/22	PRICE SENSITIVE	1018.22KB	Share
DNA 1H FY22 Results Summary
28/02/22	PRICE SENSITIVE	187.3KB	Share
DNA Appendix 4D and Half Year Financial Report
28/02/22	PRICE SENSITIVE	629.32KB	Share
DNA Quarterly Activities Report & Appendix 4C - 31 December 2021
31/01/22	PRICE SENSITIVE	421.23KB	Share
DNA Results of Annual General Meeting
28/01/22		190.39KB	Share
DNA AGM 2021 - Investor Presentation
28/01/22		950.05KB	Share
DNA AGM 2021 - Chairman's Address
28/01/22		165.3KB	Share
DNA Mega Bank Facility Repaid
05/01/22		159.4KB	Share
DNA Notice of Annual General Meeting/Proxy Form
24/12/21		1.25MB	Share
DNA Appendix 4C Cash Flow Report
29/10/21	PRICE SENSITIVE	247.45KB	Share
DNA Quarterly Activities Report
29/10/21	PRICE SENSITIVE	244.64KB	Share
DNA Appendix 4G and FY21 Corporate Governance Statement
30/09/21		424.89KB	Share
DNA FY21 Annual Report and Audited Accounts
30/09/21		1.85MB	Share
DNA FY21 Results Presentation
31/08/21		1.45MB	Share
DNA FY21 Results Commentary
31/08/21	PRICE SENSITIVE	213.28KB	Share
DNA Appendix 4E and Preliminary Final Report
31/08/21	PRICE SENSITIVE	185.21KB	Share
DNA Quarterly Activities Report
30/07/21	PRICE SENSITIVE	239.22KB	Share
DNA Appendix 4C Cash Flow Report
30/07/21	PRICE SENSITIVE	152.9KB	Share
DNA Change of Registered Office Address
07/07/21		132.53KB	Share
DNA Status of Mega Bank Facility
01/07/21	PRICE SENSITIVE	163.56KB	Share
DNA Quarterly Activities Report & Appendix 4C - 31 March 2021
30/04/21	PRICE SENSITIVE	505.58KB	Share
DNA Temporary Closure of Star Vegas
28/04/21	PRICE SENSITIVE	152.66KB	Share
DNA 1H FY21 Results Investor Briefing Q&A
05/03/21		239.05KB	Share
DNA 1H FY21 Investor Presentation
26/02/21		868.85KB	Share
DNA 1H FY21 Results Summary
26/02/21	PRICE SENSITIVE	210.13KB	Share
DNA Appendix 4D and Half Year Financial Report
26/02/21	PRICE SENSITIVE	545.53KB	Share
DNA 1H FY21 Results Investor Briefing
18/02/21		152.25KB	Share
DNA Change of Director's Interest Notice
01/02/21		369.33KB	Share
DNA Quarterly Activities Report & Appendix 4C - 31 December 2020
29/01/21	PRICE SENSITIVE	474.53KB	Share
DNA Donaco completes Star Vegas settlement
11/01/21		149.22KB	Share
DNA Lender approval received for Star Vegas settlement
22/12/20	PRICE SENSITIVE	155.78KB	Share
DNA Final Director's Interest Notice
22/12/20		171.4KB	Share
DNA Final Director's Interest Notice
22/12/20		170.9KB	Share
DNA Results of Meeting
21/12/20		189.58KB	Share
DNA AGM 2020 - CEO Presentation
21/12/20	PRICE SENSITIVE	1.03MB	Share
DNA AGM 2020 - Chairman's Address
21/12/20		165.94KB	Share
DNA 2020 AGM - Withdrawal of Resolutions 7 and 8
21/12/20		156.85KB	Share
DNA Board Composition Changes
21/12/20		147.08KB	Share
DNA DNA returns to positive EBITDA as COVID-19 impacts subside
18/12/20	PRICE SENSITIVE	171.48KB	Share
DNA Virtual Meeting Online User Guide
19/11/20		891.99KB	Share
DNA Notice of Annual General Meeting and Proxy Form
19/11/20		1.08MB	Share
DNA Appendix 4G and FY20 Corporate Governance Statement
30/10/20		486.27KB	Share
DNA FY20 Annual Report and Audited Accounts
30/10/20		2.01MB	Share
DNA Quarterly Activities Report & Appendix 4C - 30 Sept 2020
30/10/20	PRICE SENSITIVE	1022.05KB	Share
DNA Limited Reopening of DNA Star Vegas
25/09/20		149.68KB	Share
DNA Final Director's Interest Notice - Vertullo
07/09/20		168.51KB	Share
DNA Initial Director's Interest Notice - Intrapaiboon
03/09/20		167.41KB	Share
DNA Final Director's Interest Notice - Ashton
03/09/20		169.56KB	Share
DNA Initial Director's Interest Notice - Phillips
03/09/20		170.83KB	Share
DNA Board and CEO Appointments
03/09/20		206.75KB	Share
DNA FY20 Results Presentation
01/09/20		1.01MB	Share
DNA FY20 Results Commentary
01/09/20		272.99KB	Share
DNA Preliminary Final Report
01/09/20	PRICE SENSITIVE	361.69KB	Share

REFRESH

1 2 3 4 5 6

(20min delay)
Last 4.0¢		Change 0.004(11.1%)		Mkt cap ! $49.41M

Open	High	Low	Value	Volume
3.5¢	4.0¢	3.5¢	$98.17K	2.656M

Buyers (Bids)

No.	Vol.	Price($)
1	15089	3.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	33210	1

View Market Depth

No.	Vol.	Price($)
1	15089	0.038
1	60709	0.037
1	300000	0.036
3	189386	0.035
2	117675	0.034

Price($)	Vol.	No.
0.041	78720	1
0.042	942000	3
0.045	186270	1
0.046	220001	1
0.049	15384	1

Last trade - 16.10pm 10/05/2024 (20 minute delay)


Last 3.8¢		Change 0.004 ( 5.56 %)
Open	High	Low	Volume
3.7¢	3.8¢	3.7¢	134855
Last updated 15.31pm 10/05/2024 ?

DNA (ASX) Chart

DONACO INTERNATIONAL LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available